Genomics sequencing platforms and instruments are poised for significant growth, driven by expanding clinical adoption in precision medicine and oncology, coupled with transformative innovations in multi-omics and AI-driven drug discovery.
7 tickers·$594.11B market cap
10D-6.46%#1,257of 1,461 themes/1,461#2of 5 in Genomics/5 Genomics